Please login to the form below

Not currently logged in
Email:
Password:

EPO

This page shows the latest EPO news and features for those working in and with pharma, biotech and healthcare.

Astellas files new application for expanded use of roxadustat in Japan

Astellas files new application for expanded use of roxadustat in Japan

It is thought that mechanism causes lower but more consistent EPO levels in the blood.

Latest news

More from news
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    product. (According to the journal Biosimilar Development the price of EPO in Norway was sold at an 83% discount from the original price.).

  • Can biosimilars live up to the hype? Can biosimilars live up to the hype?

    For instance, in Germany, an estimated 0.5bn has been saved with the introduction of Epo biosimilars and there has been a dramatic expansion in the use of the biosimilar filgrastim

  • Deal Watch February 2016 Deal Watch February 2016

    licence. 105. †† Genexine/ Shanghai Chemo WanBang Biopharma. GX-E2 (EPO-hyFc), a novel Fc-engineered (hyFc) long acting EPO, for anaemia due to chronic kidney disease and chemotherapy.

  • An eye towards the biobetter in South Korea An eye towards the biobetter in South Korea

    EPO-Fc. EPO-hybrid Fc. Anaemia. S Korea. Phase I. Hanferon (HL143). HanAll Biopharma. ... Hormone deficiency. S Korea. Phase I Completed Dec 2011. HL033. Improved EPO.

  • Country report: The healthcare market in Germany Country report: The healthcare market in Germany

    For instance, the launch of EPO has contributed to considerable public savings.OTC drugs are sold in pharmacies only (some herbal medicines and supplements can be sold in other stores) and

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics